Abbott took "a deliberately very different development path ... for the waveform" behind its Volt PFA system, said Dr.

TidalHealth Peninsula Regional is now the first in the area to offer the innovative robotic convergent procedure ...

Johnson & Johnson MedTech (NYSE: JNJ) announced 12-month data from its SmartfIRE clinical trial of the ThermoCool SmartTouch ...

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

Abbott ABT recently announced CE Mark approval for the Volt Pulsed Field Ablation (“PFA”) system to treat patients battling atrial fibrillation (AFib). The development came earlier than expected, ...

SmartfIRE 12-month data demonstrated 86.9% effectiveness when utilized with high adherence to the recommended ablation workflow and significant quality of life improvements using the Dual Energy ...

For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various ...

The SINGLE SHOT CHAMPION study increases momentum for PFA as a first-line option for pulmonary vein isolation, say experts.

The Naples Comprehensive Health Rooney Heart Institute successfully completed a clinical trial of the Affera Mapping and Ablation System featuring the Sphere-9 Catheter.

Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...

Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...

There are worries about delayed complications, but many places won’t get paid if AF patients don’t spend the night in ...